Personalized Immunotherapy in Osteoarthritis: A Clinical Trial of Autologous Dendritic Cell Immunotherapy in Knee Osteo-Arthritis
Current Issues in Molecular Biology · 20.03.2026 · 48 (3) · 330
DOI: 10.3390/cimb48030330 ↗Kurz gefasst
Fachartikel in der Zeitschrift Current Issues in Molecular Biology, online erschienen am 20.03.2026. Verfasst von Kurniawan Silalahi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, Dentistry, and Health Sciences, Universitas Prima Indonesia, Medan 20118, Indonesia. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/Objectives: Osteoarthritis (OA) is a chronic inflammatory disease with limited disease-modifying therapies. This study explored a novel immunomodulatory approach using autologous, antigen-pulsed semi-mature dendritic cells (DCs) to modulate the inflammatory milieu in knee OA patients.
Methods
In this open-label, quasi-experimental study, 29 subjects received a single subcutaneous injection of autologous DCs. Outcomes assessed at baseline and 4 weeks included the WOMAC index for symptoms and serum levels of IL-6 and TNF-α. Responses were analyzed in the overall cohort and by BMI subgroups.
Results
The overall cohort showed a non-significant trend in WOMAC improvement (p = 0.080) and no change in IL-6 (p = 0.785) or TNF-α (p = 0.330). Subgroup analysis revealed differential patterns of response: WOMAC scores improved significantly only in normal-weight patients (p = 0.030), while serum TNF-α decreased significantly only in overweight patients (p = 0.025). IL-6 levels were unchanged across all groups.
Conclusions
Autologous antigen-pulsed DC administration was associated with differential responses across BMI subgroups. Symptomatic benefit was observed in normal-weight individuals, while a reduction in systemic TNF-α occurred in overweight patients. These findings suggest that the host metabolic state may modulate the response to DC-based immunotherapy, and therefore warrant validation in a randomized, placebo-controlled trial.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Faculty of Medicine, Dentistry, and Health Sciences, Universitas Prima Indonesia, Medan 20118, Indonesia.
- Department of Orthopaedic and Traumatology, Slamet Riyadi Army Hospital, Surakarta 57148, Indonesia.
- Faculty of Medicine, Universitas Pembangunan Nasional "Veteran" Jakarta, Jakarta 12450, Indonesia.
- Indonesia Army Cellcure Center, Gatot Soebroto Central Army Hospital, Jakarta 10410, Indonesia.
- Faculty of Military Medicine, Indonesia Defense University, Bogor 16810, Indonesia.
- Nephrology Division, Department of Internal Medicine, Gatot Soebroto Central Army Hospital, Jakarta 10410, Indonesia.
Zitieren
APA
Silalahi, K., Hernowo, B. A., Jonny, J., Sagoro, L., Ginting, C. N., & Putranto, T. A. (2026). Personalized Immunotherapy in Osteoarthritis: A Clinical Trial of Autologous Dendritic Cell Immunotherapy in Knee Osteo-Arthritis. Current Issues in Molecular Biology, 48(3), 330. https://doi.org/10.3390/cimb48030330
Vancouver
Silalahi K, Hernowo BA, Jonny J, Sagoro L, Ginting CN, Putranto TA. Personalized Immunotherapy in Osteoarthritis: A Clinical Trial of Autologous Dendritic Cell Immunotherapy in Knee Osteo-Arthritis. Current Issues in Molecular Biology. 2026;48(3):330. doi:10.3390/cimb48030330
BibTeX
@article{Silalahi2026,
author = {Silalahi, Kurniawan and Hernowo, Bhimo Aji and Jonny, Jonny and Sagoro, Lintang and Ginting, Chrismis Novalinda and Putranto, Terawan Agus},
title = {Personalized Immunotherapy in Osteoarthritis: A Clinical Trial of Autologous Dendritic Cell Immunotherapy in Knee Osteo-Arthritis},
journal = {Current Issues in Molecular Biology},
year = {2026},
volume = {48},
number = {3},
pages = {330},
doi = {10.3390/cimb48030330}
}
EUVIMED